Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL14638 (Ciproxifan) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
acetylcholinesterase (Yt blood group)/Acetylcholinesterase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL220] [GtoPdb: 2465] [UniProtKB: P22303] | ||||||||
ChEMBL | Inhibition of human AChE | B | 4.06 | pIC50 | 86100 | nM | IC50 | Eur J Med Chem (2019) 180: 690-706 [PMID:31401465] |
ChEMBL | Inhibition of human acetylcholinesterase expressed in HEK 293 cells using acetylthiocholine iodide as substrate by Ellman's method | B | 4.06 | pIC50 | 86100 | nM | IC50 | Bioorg Med Chem (2019) 27: 895-930 [PMID:30744931] |
A1 receptor/Adenosine A1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL226] [GtoPdb: 18] [UniProtKB: P30542] | ||||||||
ChEMBL | Displacement of [3H]CCPA from human recombinant adenosine A1 receptor expressed in CHO cells by liquid scintillation counting analysis | B | 6 | pKi | >1000 | nM | Ki | J Med Chem (2021) 64: 8246-8262 [PMID:34107215] |
A2A receptor/Adenosine A2a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL251] [GtoPdb: 19] [UniProtKB: P29274] | ||||||||
ChEMBL | Displacement of [3H]MSX-2 from human recombinant adenosine A2A receptor expressed in CHO cells by liquid scintillation counting analysis | B | 6 | pKi | >1000 | nM | Ki | J Med Chem (2021) 64: 8246-8262 [PMID:34107215] |
A2B receptor/Adenosine A2b receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL255] [GtoPdb: 20] [UniProtKB: P29275] | ||||||||
ChEMBL | Displacement of [3H]PSB-603 from human recombinant adenosine A2B receptor expressed in CHO cells by liquid scintillation counting analysis | B | 6 | pKi | >1000 | nM | Ki | J Med Chem (2021) 64: 8246-8262 [PMID:34107215] |
A3 receptor/Adenosine A3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL256] [GtoPdb: 21] [UniProtKB: P0DMS8] | ||||||||
ChEMBL | Displacement of [3H]PSB-11 from human recombinant adenosine A3 receptor expressed in CHO cells by liquid scintillation counting analysis | B | 6 | pKi | >1000 | nM | Ki | J Med Chem (2021) 64: 8246-8262 [PMID:34107215] |
α2A-adrenoceptor/Alpha-2a adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1867] [GtoPdb: 25] [UniProtKB: P08913] | ||||||||
ChEMBL | Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells | B | 7.37 | pKi | 42.66 | nM | Ki | J Med Chem (2008) 51: 5423-5430 [PMID:18683917] |
α2C-adrenoceptor/Alpha-2c adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1916] [GtoPdb: 27] [UniProtKB: P18825] | ||||||||
ChEMBL | Displacement of [3H]rauwolscine from human adrenergic alpha 2C4 receptor expressed in mouse LTK- cells | B | 7.2 | pKi | 63.1 | nM | Ki | J Med Chem (2008) 51: 5423-5430 [PMID:18683917] |
butyrylcholinesterase/Butyrylcholinesterase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1914] [GtoPdb: 2471] [UniProtKB: P06276] | ||||||||
ChEMBL | Inhibition of human BChE | B | 4.11 | pIC50 | 77300 | nM | IC50 | Eur J Med Chem (2019) 180: 690-706 [PMID:31401465] |
ChEMBL | Inhibition of human plasma butyrylcholinesterase by Ellman's method | B | 4.11 | pIC50 | 77300 | nM | IC50 | Bioorg Med Chem (2019) 27: 895-930 [PMID:30744931] |
H1 receptor/Histamine H1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL231] [GtoPdb: 262] [UniProtKB: P35367] | ||||||||
GtoPdb | - | - | 5 | pKi | >10000 | nM | Ki | Pharmacol Rev (2015) 67: 601-55 [PMID:26084539] |
ChEMBL | Displacement of [3H]mepyramine from human histamine H1 receptor | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (2008) 51: 5423-5430 [PMID:18683917] |
ChEMBL | Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay | B | 5.6 | pKi | >2511.89 | nM | Ki | Bioorg Med Chem Lett (2013) 23: 6897-6901 [PMID:24161834] |
H2 receptor/Histamine H2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1941] [GtoPdb: 263] [UniProtKB: P25021] | ||||||||
GtoPdb | - | - | 5 | pKi | >10000 | nM | Ki | Pharmacol Rev (2015) 67: 601-55 [PMID:26084539] |
ChEMBL | Displacement of [3H]tiotidine from human histamine H2 receptor | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (2008) 51: 5423-5430 [PMID:18683917] |
H3 receptor/Histamine H3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL264] [GtoPdb: 264] [UniProtKB: Q9Y5N1] | ||||||||
ChEMBL | Displacement of [3H] N-alpha methylhistamine from human recombinant histamine H3 receptor expressed in HEK293 cells measured after 90 mins | B | 6.65 | pKi | 224 | nM | Ki | J Med Chem (2021) 64: 8246-8262 [PMID:34107215] |
ChEMBL | Antagonist potency against human H3 receptor in GTPgamma-S-Assay | F | 7.03 | pKi | 94 | nM | Ki | J Med Chem (2005) 48: 306-311 [PMID:15634025] |
ChEMBL | Antagonist potency against human histamine H3 receptor expressed in CHO cells was determined by GTPgamma-S-assay | F | 7.03 | pKi | 94 | nM | Ki | J Med Chem (2004) 47: 2833-2838 [PMID:15139761] |
ChEMBL | Displacement of [3H]NAMH from histamine H3 receptor in human cortex | B | 7.05 | pKi | 89.13 | nM | Ki | J Med Chem (2008) 51: 5423-5430 [PMID:18683917] |
ChEMBL | Displacement of [3H]NAMH from human full length histamine H3 receptor expressed in rat C6 cells | B | 7.2 | pKi | 63.1 | nM | Ki | J Med Chem (2008) 51: 5423-5430 [PMID:18683917] |
ChEMBL | In vitro binding affinity was determined as displacement of [3H]N-R-methylhistamine from C6 cell membranes expressing human histamine H3 receptor | B | 7.2 | pKi | 63.1 | nM | Ki | J Med Chem (2005) 48: 38-55 [PMID:15634000] |
ChEMBL | Antagonist activity at human histamine H3 receptor expressed in CHOK1 cells assessed as inhibition of GTPgammaS binding by scintillation proximity assay | F | 7.2 | pKi | 63.1 | nM | Ki | Bioorg Med Chem Lett (2013) 23: 6897-6901 [PMID:24161834] |
ChEMBL | In vitro binding affinity was determined as displacement of [3H]N-R-methylhistamine from C6 cell membranes expressing human histamine H3 receptor | B | 7.2 | pKi | 63 | nM | Ki | J Med Chem (2005) 48: 38-55 [PMID:15634000] |
ChEMBL | Binding affinity to human H3R | B | 7.2 | pKi | 63 | nM | Ki | Eur J Med Chem (2021) 213: 113041-113041 [PMID:33261900] |
ChEMBL | Binding affinity to human H3 receptor | B | 7.2 | pKi | 63 | nM | Ki | J Med Chem (2012) 55: 2406-2415 [PMID:22313227] |
GtoPdb | - | - | 7.3 | pKi | - | - | - |
J Pharmacol Exp Ther (2003) 305: 887-96 [PMID:12606603]; Biochem Pharmacol (2004) 68: 933-45 [PMID:15294456]; Biochem J (2001) 355: 279-88 [PMID:11284713]; Br J Pharmacol (2000) 131: 1247-50 [PMID:11090094]; Eur J Pharmacol (2002) 453: 33-41 [PMID:12393057]; Pharmacol Rev (2015) 67: 601-55 [PMID:26084539] |
ChEMBL | Displacement of [3H]UR-PI294 from human SP-FLAG-tagged H3R expressed in HEK293T cells measured after 60 to 120 mins by liquid scintillation counting analysis | B | 7.31 | pKi | 48.9 | nM | Ki | Eur J Med Chem (2021) 213: 113041-113041 [PMID:33261900] |
ChEMBL | Displacement of [125I]iodoproxyfan from human full-length histamine H3 receptor expressed in HEK293 cells after 60 mins | B | 7.34 | pKi | 46 | nM | Ki | Bioorg Med Chem (2011) 19: 2850-2858 [PMID:21498080] |
ChEMBL | Displacement of [125I]iodoproxyfan from human histamine H3 receptor expressing CHO cells | B | 7.34 | pKi | 46 | nM | Ki | J Med Chem (2003) 46: 1523-1530 [PMID:12672253] |
ChEMBL | Displacement of [3H]iodoproxyfan from human histamine H3 receptor expressed in CHO-K1 cells | B | 7.34 | pKi | 46 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 6682-6685 [PMID:19846299] |
ChEMBL | Inhibition of [125I]iodoproxyfan binding to human histamine H3 receptor of CHO-K1 cells | B | 7.34 | pKi | 46 | nM | Ki | Bioorg Med Chem Lett (2001) 11: 951-954 [PMID:11294398] |
ChEMBL | Displacement of [3H]Nalpha-methylhistamine from human recombinant histamine H3 receptor expressed in HEK-293 cells | B | 7.34 | pKi | 46 | nM | Ki | ACS Med Chem Lett (2013) 4: 269-273 [PMID:24900647] |
ChEMBL | Binding affinity to human H3R | B | 7.34 | pKi | 46 | nM | Ki | Eur J Med Chem (2018) 148: 487-497 [PMID:29477889] |
ChEMBL | Inhibition of human histamine H3 receptor | B | 7.34 | pKi | 46 | nM | Ki | Eur J Med Chem (2019) 180: 690-706 [PMID:31401465] |
ChEMBL | Displacement of [3H]-N-alpha-methylhistamine from human H3R expressed in HEK293 cell membranes incubated for 90 mins by liquid scintillation counting method | B | 7.34 | pKi | 46 | nM | Ki | Bioorg Med Chem (2019) 27: 895-930 [PMID:30744931] |
H3 receptor in Mouse [GtoPdb: 264] [UniProtKB: P58406] | ||||||||
GtoPdb | - | - | 9.4 | pKi | - | - | - | J Neurochem (2004) 90: 1331-8 [PMID:15341517] |
H3 receptor/Histamine H3 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4124] [GtoPdb: 264] [UniProtKB: Q9QYN8] | ||||||||
ChEMBL | Inhibition of [125I]iodoproxyfan from rat histamine H3 receptor expressed in CHO-K1 cells | B | 8.41 | pKi | 3.9 | nM | Ki | Bioorg Med Chem Lett (2001) 11: 951-954 [PMID:11294398] |
ChEMBL | Displacement of [3H]NAMH from histamine H3 receptor in rat cortex | B | 9.2 | pKi | 0.63 | nM | Ki | J Med Chem (2008) 51: 5423-5430 [PMID:18683917] |
ChEMBL | In vitro binding affinity was determined as displacement of [3H]N-R-methylhistamine from C6 cell membranes expressing rat histamine H3 receptor | B | 9.29 | pKi | 0.51 | nM | Ki | J Med Chem (2005) 48: 38-55 [PMID:15634000] |
ChEMBL | Displacement of [3H]NAMH from rat full length histamine H3 receptor expressed in rat C6 cells | B | 9.29 | pKi | 0.51 | nM | Ki | J Med Chem (2008) 51: 5423-5430 [PMID:18683917] |
ChEMBL | In vitro binding affinity was determined as displacement of [3H]N-R-methylhistamine from C6 cell membranes expressing rat histamine H3 receptor | B | 9.29 | pKi | 0.51 | nM | Ki | J Med Chem (2005) 48: 38-55 [PMID:15634000] |
GtoPdb | - | - | 9.3 | pKi | - | - | - |
J Pharmacol Exp Ther (2003) 305: 887-96 [PMID:12606603]; Biochem Pharmacol (2004) 68: 933-45 [PMID:15294456]; Biochem Biophys Res Commun (2001) 280: 75-80 [PMID:11162480]; Br J Pharmacol (2000) 131: 1247-50 [PMID:11090094]; Eur J Pharmacol (2002) 453: 33-41 [PMID:12393057] |
ChEMBL | In vitro binding affinity against rat histamine H3 receptor | B | 9.31 | pKi | 0.49 | nM | Ki | J Med Chem (2004) 47: 2678-2687 [PMID:15115409] |
ChEMBL | In vitro inhibitory activity against Histamine H3 receptor for K+ evoked depolarization-induced release of [3H]histamine from synaptosomes of rat cerebral cortex | B | 9.31 | pKi | 0.49 | nM | Ki | Bioorg Med Chem Lett (2000) 10: 2379-2382 [PMID:11055360] |
ChEMBL | Histamine H3 receptor antagonist activity in an assay with K+ evoked depolarization-induced release of [3H]-histamine from rat synaptosomes. | F | 9.31 | pKi | 0.49 | nM | Ki | J Med Chem (2000) 43: 3335-3343 [PMID:10966752] |
H4 receptor/Histamine H4 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3759] [GtoPdb: 265] [UniProtKB: Q9H3N8] | ||||||||
ChEMBL | Displacement of [3H]histamine from human histamine H4 receptor expressed in HEK cells | B | 5.73 | pKi | 1862.09 | nM | Ki | J Med Chem (2008) 51: 5423-5430 [PMID:18683917] |
GtoPdb | - | - | 5.73 | pKi | - | - | - |
J Pharmacol Exp Ther (2003) 305: 887-96 [PMID:12606603]; Biochem Pharmacol (2004) 68: 933-45 [PMID:15294456]; Pharmacol Rev (2015) 67: 601-55 [PMID:26084539] |
ChEMBL | Displacement of [3H]histamine from human histamine H4 receptor expressed in HEK293 cells | B | 6.21 | pKi | 612 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 6682-6685 [PMID:19846299] |
ChEMBL | Displacement of [3H]histamine from human full-length histamine H4 receptor expressed in HEK293 cells after 60 mins | B | 6.21 | pKi | 612 | nM | Ki | Bioorg Med Chem (2011) 19: 2850-2858 [PMID:21498080] |
Monoamine oxidase A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1951] [GtoPdb: 2489] [UniProtKB: P21397] | ||||||||
ChEMBL | Inhibition of human MAOA | B | 4.94 | pIC50 | 11400 | nM | IC50 | Eur J Med Chem (2019) 180: 690-706 [PMID:31401465] |
ChEMBL | Inhibition of recombinant human MAOA expressed in baculovirus infected BTI insect cells using p-tyramine as substrate by Amplex red reagent/horseradish peroxidase coupled fluorescence assay | B | 4.94 | pIC50 | 11400 | nM | IC50 | Bioorg Med Chem (2019) 27: 895-930 [PMID:30744931] |
ChEMBL | Inhibition of human MAO-A expressed in baculovirus infected insect cell membranes using kynuramine as substrate up to 30 mins by spectrophotometric method | B | 4.96 | pIC50 | 11000 | nM | IC50 | Eur J Med Chem (2018) 148: 487-497 [PMID:29477889] |
Monoamine oxidase B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2039] [GtoPdb: 2490] [UniProtKB: P27338] | ||||||||
ChEMBL | Inhibition of human MAO-B expressed in baculovirus infected insect cell membranes using kynuramine as substrate up to 30 mins by spectrophotometric method | B | 5.68 | pIC50 | 2100 | nM | IC50 | Eur J Med Chem (2018) 148: 487-497 [PMID:29477889] |
ChEMBL | Inhibition of recombinant human MAOB expressed in baculovirus infected BTI insect cells using p-tyramine as substrate by Amplex red reagent/horseradish peroxidase coupled fluorescence assay | B | 5.68 | pIC50 | 2100 | nM | IC50 | Bioorg Med Chem (2019) 27: 895-930 [PMID:30744931] |
ChEMBL | Inhibition of human MAOB | B | 5.72 | pIC50 | 1900 | nM | IC50 | Eur J Med Chem (2019) 180: 690-706 [PMID:31401465] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]